Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$786.8K
230K shares
What this filing means
BORGESON BLAKE plans to sell 230K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $786.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/5/2026ACC: 0001959173-26-003266
Director
Since Apr 2021
230K
Shares to sell
$786.8K
Approx. market value
30K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
9/19/2017
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2017 | Founders Shares Compensation | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
30K
Market value
$93.0K
4/7/2026
—Completed
Units to sell
170K
Market value
$588.2K
3/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$105.6K
5/5/2026
Total
Units
230K
Value
$786.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/7/2026 | 30K | $93.0K | — | Completed |
3/3/2026 | 170K | $588.2K | — | Completed |
| Planned — Approximate Date | ||||
5/5/2026 | 30K | $105.6K | NASDAQ | Planned |
| Total | 230K | $786.8K | ||